The U.S. Supreme Court, in its Minerva Surgical v. Hologic ruling today preserved the legal doctrine of assignor estoppel — that inventors who sell patent rights can’t then claim they’re invalid.
However, Justice Elena Kagan, in her opinion for the majority, did say that the doctrine has limits.
Get the full story on our sister site Medical Design & Outsourcing.